Related Experiment Video

Updated: Aug 12, 2026

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols
12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Phosphorylation of transcriptional factors and cell-cycle-dependent proteins by casein kinase II

H Meisner1, M P Czech

  • 1Program in Molecular Medicine, University of Massachusetts Medical School, Worcester 10605.

Current Opinion in Cell Biology
|June 1, 1991
PubMed

Insights

Casein kinase II (CK2) phosphorylates key regulatory proteins, impacting cell cycle control. This enzyme is crucial for cell cycle regulation mechanisms, highlighting its role in cancer development.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Biochemistry

Background:

  • Casein kinase II (CK2) is a ubiquitous serine/threonine protein kinase.
  • CK2 plays a role in various cellular processes, including cell growth, proliferation, and survival.
  • Dysregulation of CK2 activity is implicated in several human diseases, particularly cancer.

Purpose of the Study:

  • To evaluate the role of CK2 in the phosphorylation of nuclear transcriptional regulatory factors.
  • To investigate the functional significance of CK2-mediated phosphorylation in proto-oncogenes, anti-oncogenes, and oncogenes.
  • To determine if CK2 is a critical component in cell cycle regulation.

Main Methods:

  • Analysis of CK2 activity in relation to cell cycle progression.
  • Phosphorylation assays using specific substrates.
  • Western blot analysis to detect phosphorylated proteins.

Main Results:

  • CK2 phosphorylates numerous nuclear transcriptional regulatory factors, including proto-oncogenes, anti-oncogenes, and oncogenes.
  • Phosphorylation by CK2 influences the activity and function of these regulatory proteins.
  • Evidence suggests CK2 is integral to the mechanisms governing cell cycle progression.

Conclusions:

  • CK2-mediated phosphorylation is a key regulatory mechanism for nuclear transcriptional factors.
  • CK2 plays a critical role in controlling cell cycle progression.
  • Targeting CK2 may offer therapeutic strategies for diseases involving cell cycle dysregulation.

More Related Videos

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay12:26

Identification of Cyclin-dependent Kinase 1 Specific Phosphorylation Sites by an In Vitro Kinase Assay

Published on: May 3, 2018

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach11:11

Identification of Novel CK2 Kinase Substrates Using a Versatile Biochemical Approach

Published on: February 21, 2019

Related Concept Videos

Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Calmodulin-dependent Signaling01:16

Calmodulin-dependent Signaling

Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...